Patients with autoimmune thyroid diseases have antibodies to plasmid encoded proteins of enteropathogenic Yersinia by Wenzel, B. E. et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 
Official Journal of the Italian Society of Endocrinology 
Volume 11 February 1988 Number 2 
CONTENTS 
Hormonal responses in pubertal males to pulsatile gonadotropin 
releasing hormone (GnRH) administration 
D. Gordon, H.N. Cohen, G.H. Beastall, B. Perry, and JA. Thomson 77 
Quantitative immunological differences between newly diagnosed Graves' 
disease patients and relapsed patients 
U. Di Mario, F.P. Cavatorta, R. Perfetti, G. Pugliese, 
P. Pozzilli, J. Sutherland, M. Vitillo, and D. Andreani 85 
Primary familial hypoparathyroidism with an autosomal dominant mode of inheritance 
C. De Campo, L Piscopello, C. Noacco, P. Da Col, G.C. Englaro, and A. Benedetti 91 
Thyroid function in patients with Pendred's Syndrome 
J. Friis, T. Johnsen, U. Feldt-Rasmussen, K. Bech, and T. Friis 97 
The pineal gland-opioid System relation: melatonin-naloxone interactions in regulating 
GH and LH releases in man 
D. Esposti, P. Lissoni, R. Mauri, F. Rovelli, L. Orsenigo, S. Pescia, 
G. Vegetti, G. Esposti, and F. Fraschini 103 
Thyroid Carcinoma in thyrotoxic patients treated.by surgery 
F. Pacini, R. Elisei, G.C. Di Coscio, S. Anelli, E. Macchia, R. Concetti, 
P. Miccoli, M. Arganini, and A. Pinchera 107 
Dissociated thyromimetic effects of 3. 5, 3'-triiodothyroacetic acid (TRIAC) 
at the pituitary and peripheral tissue levels 
P. Beck-Peccoz, A. Sartorio, C. De Medici, G. Grugni, F. Morabito, and G. Faglia 113 
Plasma B-endorphin resistance to dexamethasone suppression in obese patients 
F. Facchinetti, C. Giovannini, F. Petraglia, C. Barletta, 
G. Comitini, and A.R. Genazzani 119 
Oxytocin response to insulin-induced hypoglycemia in obese subjects 
before and after weight loss 
V. Coiro, M. Passeri, C. Davoli, L d'Amato, G. Gelmini, F. Fagnoni, L. Schianchi, 
M. Bentivoglio, R. Volpi, and P. Chiodera 125 
CASE REPORT 
Factitious transient neonatal hyperthyrotropinemia 
N. Jospe, G.D. Berkovitz, LE. Corcoran, and R.L Humphrey 129 
COMMENT 
Measurement of catecholamines, met-enkephalin,somatostatin and substance P-like 
immunoreactivities in 12 human pheochromocytomas 
E. Baldi, M.L De Feo, P. Geppetti, V. Carla, M. Maggi, C. Pupilli, 




Patients with autoimmune thyroid diseases have antibodies to 
Plasmid encoded proteins of enteropathogenic Yersinia 
B.E. Wenzel, J. Heesemann, K.W. Wenzel, and P.C. Scriba 139 
Comparison of complement fixation and radioassay techniques to detect solubilized 
human thyroid microsomal antigenic activity 
S. Mariotti, M.E. Medof, S. Anelli, A. Pinchera, and LJ. DeGroot 141 
REVIEW ARTICLE 
Regulation of thyroid-stimulating hormone (TSH) secretion in the fetus and neonate 
E.Roti 145 
ANNOUNCEMENTS 
II Meeting Mediterranean Group for the Study of Diabetes 84 
Endocrinology under 35 90 
LIM Congress of the Belgian Society of Urology: Male Infertility Sexology 90 
Eshre Course on: Pre- and -Early Post-Implantation Human Pregnancy: 
Basic Concepts and Surveillance Methods 102 
International Symposium on Insulin and the Cell Membrane 124 
IV 
J. Endocrinol. Invest. 11:139,1988 
SHORT C O M M U N I C A T I O N 
Patients with autoimmune thyroid diseases have antibodies to 
Plasmid encoded proteins of enteropathogenic Yersinia1 
B.E. Wenzel*, J. Heesemann**, K.W. Wenzel***, and P.C. Scriba* 
*Depar tment of Internal Medic ine, Med. Universi ty Lübeck , FRG, ** lnst i tute of Med. Microb io logy and 
Immunology, University of Hamburg, FRG, and ***Free Universi ty of Berl in, FRG 
INTRODUCTION 
There is a striking association between autoimmune 
thyroid disease (AITD) and humoral (1,2) or cellular (1 , 
3) immunity to Yersinia enterocolitica, which also has 
binding Sites forthyrotropin (4).The role Yersinia might 
play in the pathogenesis of AITD has not yet been 
understood. This is partly due to the fact that most 
studies were done with laboratory strains of Yersinia 
enterocolitica of different serotypes, which had lost 
their virulence. Recently, it became evident, that a pre-
requisite to virulence of the most common enteropatho-
genic Yersinia enterocolitica (Y.e.) and Yersinia pseu-
dotuberculosis (Y.p.) strains is the presence of a 42 to 
46 Megadalton plasmid which is rapidly lost after sub-
cultivation (5). These virulence plasmids of the differ-
ent serotypes and species of Yersinia are closely relat-
ed. Virulence function such as serum resistance, pha-
gocytosis resistance and cell adherence are mediated 
by these plasmids (6, 7). Furthermore, these plasmids 
encode for at least 6 proteins against which humans 
and animals produce antibodies after Yersinia infection 
(8,9). In calcium- deficient nutrient broth virulent Yersi-
nia releases these immunogenetic proteins (RPs) in 
high quantities (6, 8). On SDS-PAGE protein bands of 
RPs can be visualized at 25 kD, 34 (Y.p.)/36 (Y.e.) kD, 
38 kD, 46 kD and 58 (Y.e.)/67 (Y.p.) kD. Using mouse 
monoclonal and polyclonal antibodies to RPs we could 
demonstrate a high degree of crossreactivity between 
RPs of different strains (8,10). Thus, detection of serum 
antibodies to RPs should be indicative for an acute or 
recent infection with a virulent Yersinia species. 
PATIENTS PROFILE AND METHODS 
Sera from patients with AITD were investigated for 
antibodies to RPs and for the prevalence of specific 
immunoglobulin class IgA and IgG. For this the West-
1 Supported by: Deutsche Forschungsgemeinschaft *SFB 232/C4, **He-1297/1 -4. 
Key-words: Autoimmune thyroid diseases, enteropathogenic Yersinia, Yersinia 
Plasmid encoded proteins. 
Correspondence: Dr. B.E. Wenzel. Dept. Internal Med.. Cell- and Immunbio!. Lab., 
Haus 30, Med. University Lübeck, Ratzeburger Allee 160, D-2400 Lübeck 1, FRG. 
Received November 23. 1987; accepted December 20, 1987. 
ern-blotting technique was used (9). The frequencies 
of RP-antibodies in 336 healthy blood donors and 25 
patients with non toxic goiter were compared to 100 
Graves patients (GD) and 38 patients with Hashimoto's 
thyroiditis. All GD-patients were hyperthyroid and had 
TSH-receptor antibodies. The onset of GD was esti-
mated at admittance by the patients report of Symp-
toms for hyperthyroidism. Hashimoto patients (HT) 
were on thyroxin for 1 -7 years. Patients with non toxic 
goiters (NTG) were all void of thyroid antibodies. No 
abnormal frequencies of Yersinia infections were re-
ported during the time of the study. For Statistical anal-
ysis the x 2-test was used. 
RESULTS 
The frequencies of antibodies to Y.e.-RPs were 
markedly increased in patients with AITD, when com-
pared to control groups (Table 1). Antibodies of immu-
noglobulin class IgG and IgA as well as the rare antibod-
ies to the 25 kD-RP were detected. Within 12 months 
after the onset of Graves' disease both, the 25 kD and 
Table 1 - Prevalence of antibodies to plasmid encoded pro-
teins of enteropathogenic Yersinia in sera of patients with 
autoimmune thyroid diseases. 
n IgG IgA a-25 k D 2 
BD 336 (116) 34.5% (40) 1 1 % (10) 3% 
NTG 25 ( 10)40% ( 3) 12% 0 
GD 
total 100 ( 72) 72%**° (33) 33%'**° (14) 14%***c 
6 m 3 35 ( 21)60%** (11)31%** ( 3) 9%* 
12 m 3 38 ( 28) 74%" (15) 39%" (14) 36%" 
GD 
Ree. 21 ( 1.7)81%'* ( 6)28%* ( 3)14%* 
HT 38 ( 25)66%**° (14)37%**° ( 4) 10%"° 
BD-blood donors, NTG - non toxic goiter, GD - Graves' disease, Ree. 
-recurrent, HT - Hashimoto's thyroiditis; 3 -month after occurrence of 
Symptoms for hyperthyroidism; 2-antibodies to a 25 kD plasmid en-
coded protein. 
For Statistical analysis the x 2-test was used. 
*p < 0.05; **p < 0.01; ***p < 0.001 compared to BD 
°p < 0.05 compared to NTG. 
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Table 2 - Time course of antibody formation to Yersinia ente-
rocolitica release proteins in sera from patients with Graves' 
disease. 












*The onset of GD was estimated by the patients' report of first Symp-
toms for hyperthyroidism 
^IgA and IgG antibodies 
3 most ly IgG antibodies 
the IgA class antibodies peaked, decreasing thereafter 
in recurrent GD. In contrast, IgG antibodies, especially 
those to the 36 kD-RP, were persisting and increased 
with ongoing GD to 8 1 % in sera of recurrent GD. A 
prospective investigation of newly diagnosed GD-pa-
tients confirms this antibody profile (Table 2). At the 
time of diagnosis all GD-patients were void of antibod-
ies to either RP, although they had TSH-receptor antib-
odies. Within 6 months all GD patients (n = 10) deve-
loped IgA, IgG and 25 kD RP-antibodies. Thereafter, 
first 58 kD and 25 kd antibodies disappeared, while the 
36 kD antibodies were persisting in most cases. Pres-
ence or absence of antibodies to RP in sera were 
independent of the patients expressing severe endo-
crine ophthalmopathy. 
CONCLUSIONS 
We report here for the first time a strong association 
between thyroid autoimmune disease and antibodies 
against plasmid encoded proteins of enteropathogenic 
Yersinia. Crossreactivity of antibodies in AITD with 
Yersinia enterocolitica or Yersinia pseudotuberculosis 
is henceforth understood independently of epidemio-
logical distribution of Yersinia serotypes. The manifes-
tation of IgA antibodies and antibodies to 25 kD-RP 
would indicate recent or persistent Yersiniosis (8,10). 
Antibodies to the 25 kD-RP are of special interest, 
since preliminary results suggest that the 25 kD-RP 
shares antigenic epitopes with the TSH-receptor (11). 
This taken together with the profile of antibodies to Y.e. 
Plasmid encoded RPs in patients with AITD might indi-
cate antigenic mimicry between thyroid and Yersinia 
Plasmid antigens. The 25 kD antibodies, however, 
emerge later than the TSH-receptor antibodies in GD-
patients blood (Table 2). Therefore, a direct trigger of 
TSH-receptor antibodies by antigenic mimicry of the 
25 kD-RP is not likely. On the other hand, the humoral 
immune response is only a late and incomplete mirror 
of the autoimmune reaction. There might very well be 
an early cellular crossreaction of Yersinia- and thyroid 
antigens in AITD. 
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